|
Other arteriosclerosis
Citations 71-80 of 267 total displayed.
|
Past content
(since Apr 1999):
|
- Genetics
Use of a Constitutively Active Hypoxia-Inducible Factor-1 Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients: Phase I Dose-Escalation Experience
- Sanjay Rajagopalan, Jeffrey Olin, Steven Deitcher, Ann Pieczek, John Laird, P. Michael Grossman, Corey K. Goldman, Kevin McEllin, Ralph Kelly, and Nicolas Chronos
Circulation 2007;115:1234-1243; published online before print as doi:10.1161/CIRCULATIONAHA.106.607994
[Abstract]
[Full text]
- Articles
Use of a Constitutively Active Hypoxia-Inducible Factor-1 Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients. Phase I Dose-Escalation Experience
- Sanjay Rajagopalan, Jeffrey Olin, Steven Deitcher, Ann Pieczek, John Laird, P. Michael Grossman, Corey K. Goldman, Kevin McEllin, Ralph Kelly, and Nicolas Chronos
Circulation published February 19, 2007, doi:10.1161/CIRCULATIONAHA.106.607994
[Abstract]
- Health Services and Outcomes Research
Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization
- David M. Safley, John A. House, Steven B. Laster, William C. Daniel, John A. Spertus, and Steven P. Marso
Circulation 2007;115:569-575; published online before print as doi:10.1161/CIRCULATIONAHA.106.643346
[Abstract]
[Full text]
- Articles
Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization
- David M. Safley, John A. House, Steven B. Laster, William C. Daniel, John A. Spertus, and Steven P. Marso
Circulation published January 22, 2007, doi:10.1161/CIRCULATIONAHA.106.643346
[Abstract]
- Controversies in Cardiovascular Medicine
Case Against Angioplasty and Stenting of Atherosclerotic Renal Artery Stenosis
- Lance D. Dworkin and Kenneth A. Jamerson
Circulation 2007;115:271-276, doi:10.1161/CIRCULATIONAHA.106.619031
[Full text]
- Editorials
Critical Limb Ischemia and Stem Cell Research: Anchoring Hope With Informed Adverse Event Reporting
- Alan T. Hirsch
Circulation 2006;114:2581-2583, doi:10.1161/CIRCULATIONAHA.106.666719
[Full text]
- New Drugs and Technologies
Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events
- Sergio Waxman, Fumiyuki Ishibashi, and James E. Muller
Circulation 2006;114:2390-2411, doi:10.1161/CIRCULATIONAHA.105.540013
[Full text]
- Vascular Medicine
Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice
- Sabine Steffens, Fabienne Burger, Graziano Pelli, Yann Dean, Greg Elson, Marie Kosco-Vilbois, Lucienne Chatenoud, and François Mach
Circulation 2006;114:1977-1984; published online before print as doi:10.1161/CIRCULATIONAHA.106.627430
[Abstract]
[Full text]
- Articles
Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice
- Sabine Steffens, Fabienne Burger, Graziano Pelli, Yann Dean, Greg Elson, Marie Kosco-Vilbois, Lucienne Chatenoud, and François Mach
Circulation published October 16, 2006, doi:10.1161/CIRCULATIONAHA.106.627430
[Abstract]
- Molecular Cardiology
Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in Plasma: A Novel Marker of Insulin Resistance
- Aase Handberg, Klaus Levin, Kurt Højlund, and Henning Beck-Nielsen
Circulation 2006;114:1169-1176; published online before print as doi:10.1161/CIRCULATIONAHA.106.626135
[Abstract]
[Full text]
|
|
